scholarly journals Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations

2018 ◽  
Author(s):  
Ming‑Szu Hung ◽  
Yu‑Hung Fang ◽  
Yu‑Ching Lin ◽  
Jr‑Hau Lung ◽  
Meng‑Jer Hsieh ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Associated Factors ◽  
Kinase Inhibitor ◽  
Egfr Mutations ◽  
First Line ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase

scholarly journals BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

PLoS Medicine ◽  
2007 ◽  
Vol 4 (10) ◽  
pp. e315 ◽  
Author(s):  
Daniel B Costa ◽  
Balázs Halmos ◽  
Amit Kumar ◽  
Susan T Schumer ◽  
Mark S Huberman ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Egfr Mutations ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Lung Cancers ◽  
Egfr Tyrosine Kinase ◽  
Induced Apoptosis

scholarly journals The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget ◽  
2016 ◽  
Vol 7 (11) ◽  
pp. 12404-12413 ◽  
Author(s):  
Shang-Gin Wu ◽  
Yi-Nan Liu ◽  
Meng-Feng Tsai ◽  
Yih-Leong Chang ◽  
Chong-Jen Yu ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Acquired Resistance ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document